Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 53345
Gene Symbol: TM6SF2
TM6SF2
0.600 Biomarker disease BEFREE Studies that used common variants in PNPLA3, TM6SF2 and GCKR as instruments to investigate the relationship between NAFLD and coronary artery disease (CAD) have reported contrasting results. 31713012 2020
Entrez Id: 53345
Gene Symbol: TM6SF2
TM6SF2
0.600 GeneticVariation disease BEFREE TM6SF2 polymorphisms were not in Hardy-Weinberg equilibrium in our NAFLD group precluding further analysis. 31054980 2020
Entrez Id: 53345
Gene Symbol: TM6SF2
TM6SF2
0.600 GeneticVariation disease BEFREE Furthermore, we did not identify an association between the TM6SF2 E167K variant and NAFLD in the non-obese population. 31054977 2020
Entrez Id: 53345
Gene Symbol: TM6SF2
TM6SF2
0.600 GeneticVariation disease BEFREE The rs58542926 polymorphism in TM6SF2 (transmembrane 6 superfamily member 2) is a genetic factor predisposing to nonalcoholic fatty liver disease. 31356578 2020
Entrez Id: 80339
Gene Symbol: PNPLA3
PNPLA3
0.500 GeneticVariation disease BEFREE Increased liver disease mortality was associated with PNPLA3 I148M (hazard ratio (HR), 2.9; 95% confidence interval (CI), 0.9-9.8) and 148M genotypes (HR, 18.2; 95% CI, 3.5-93.8), an intermediate (HR, 3.8; 95% CI, 1.3-10.7) or high (HR, 12.6; 95% CI, 4.3-36.3) NAFLD liver fat score, and a high NAFLD fibrosis score (HR, 12.2; 95% CI, 1.9-80.6) adjusted for risk factors. 31705824 2020
Entrez Id: 80339
Gene Symbol: PNPLA3
PNPLA3
0.500 Biomarker disease BEFREE We suggest PNPLA3 genotyping may help identify patients with NAFLD at higher risk of RTI. 31519069 2020
Entrez Id: 80339
Gene Symbol: PNPLA3
PNPLA3
0.500 GeneticVariation disease BEFREE We investigated whether the common rs738409 variant in PNPLA3 gene associates with the occurrence of liver-related events and death in a large cohort of patients with NAFLD. 31419571 2020
Entrez Id: 80339
Gene Symbol: PNPLA3
PNPLA3
0.500 GeneticVariation disease BEFREE This study aimed to elucidate whether PNPLA3 I148M is involved in NF-kB-related inflammation regulation in NAFLD. 31793207 2020
Entrez Id: 80339
Gene Symbol: PNPLA3
PNPLA3
0.500 GeneticVariation disease BEFREE Notably, we also found that an additive effect of the TM6SF2 E167K and PNPLA3 I148M variants in NAFLD. 31054977 2020
Entrez Id: 80339
Gene Symbol: PNPLA3
PNPLA3
0.500 GeneticVariation disease BEFREE PNPLA3 GG subjects had an increased risk (3.29-fold) of having NAFLD when compared to CC subjects (p=0.0044, 95% CI 1.504-7.225). 31054980 2020
Entrez Id: 80339
Gene Symbol: PNPLA3
PNPLA3
0.500 GeneticVariation disease BEFREE Studies that used common variants in PNPLA3, TM6SF2 and GCKR as instruments to investigate the relationship between NAFLD and coronary artery disease (CAD) have reported contrasting results. 31713012 2020
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.400 GeneticVariation disease BEFREE ADIPOQ G rs266729 and TNF- 308 A allele are associated with obesity, MetS/NAFLD and insulin resistance. 31659105 2020
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.400 Biomarker disease BEFREE Elafibranor acts as an agonist of PPAR-α and PPAR-δ and is currently under development for the treatment of NAFLD. 31523999 2020
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease BEFREE The subjects with NAFLD had higher serum leptin and lower serum adiponectin concentrations and a higher L/A ratio than subjects without NAFLD. 31756645 2020
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.400 AlteredExpression disease BEFREE Then the HFD-induced NAFLD mice were treated with vitamin D. Next, the serum levels of TNF-α, GSH-px and malondialdehyde (MDA) were assessed using ELISA and ROS content was evaluated by flow cytometry, followed by the measurement of expression of Duox1, Duox2, SOD1, SOD2, PRDX1 I, ACC, SREBP1c, MTTP, PPARα, p53, p21 and p16 using RT-qPCR and Western blot analysis. 31756344 2020
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease BEFREE We aimed to investigate the relationship of total adiponectin, high-molecular-weight (HMW) adiponectin, and leptin with the development and improvement of non-alcoholic fatty liver (NAFL) independent of sex and weight change over a maximum of 8.5 years. 31765666 2020
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.400 AlteredExpression disease BEFREE Sex-stratified analyses showed that total and HMW adiponectin levels were significantly related to NAFL incidence only in women. 31765666 2020
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.400 Biomarker disease BEFREE Thus, miR-141/SIRT1/AMPK signaling pathway may be considered a potential target for the therapeutic management of NAFLD. 31256424 2020
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.400 Biomarker disease BEFREE The subjects with NAFLD had higher serum leptin and lower serum adiponectin concentrations and a higher L/A ratio than subjects without NAFLD. 31756645 2020
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.400 Biomarker disease BEFREE Our objectives in this study were to explore the correlation between promoter methylation of the Nrf2-Keap1 genes and NAFLD, and that investigate the effect of resveratrol on the epigenetic regulation Nrf2-Keap1 in vitro and in vivo models of NAFLD. 31838177 2020
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.400 Biomarker disease BEFREE Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway. 31173696 2020
Entrez Id: 5467
Gene Symbol: PPARD
PPARD
0.380 Biomarker disease BEFREE Elafibranor acts as an agonist of PPAR-α and PPAR-δ and is currently under development for the treatment of NAFLD. 31523999 2020
Entrez Id: 196
Gene Symbol: AHR
AHR
0.330 Biomarker disease BEFREE In vitro and in vivo approaches for identifying the role of aryl hydrocarbon receptor in the development of nonalcoholic fatty liver disease. 31730885 2020
Entrez Id: 1244
Gene Symbol: ABCC2
ABCC2
0.320 AlteredExpression disease BEFREE The expression levels of hepatic multidrug resistance-associated protein 2, responsible for biliary excretion of MPAG, were comparable in rats with NAFLD and controls; the biliary excretion of MPAG was also similar in the two groups. 31652406 2020
Entrez Id: 152831
Gene Symbol: KLB
KLB
0.320 GeneticVariation disease BEFREE We evaluated the impact of the rs17618244 G>A β-Klotho (KLB) variant on liver damage in 249 pediatric patients with biopsy-proven NAFLD and the association of this variant with the expression of hepatic and soluble KLB. 31655133 2020